Skip to content
Governance Register

← US public companies

Vyne Therapeutics Inc.

SEC CIK 1566044 · VYNE · last insider filing 2026-06-02

Directors (from insider filings)

NameCapacity as filedFilings
Domzalski David Director · President and CEO filed 2020 - 2026
Lepore Patrick G Director filed 2020 - 2025
Barbari Sharon Surrey Director filed 2020 - 2025
Basta Steven L Director · See Remarks filed 2018 - 2025
Sandoval Elisabeth Director filed 2019 - 2025
Bruno Anthony D Director filed 2020 - 2024
Borowski Christine Director filed 2024 - 2024
Edelman Joseph Director filed 2020 - 2021
Bright Rex Director filed 2020 - 2021
Hirsch Stanley Director filed 2020 - 2020
Berns Paul L Director filed 2018 - 2019
Mcgirr David W J Director filed 2018 - 2019
Whitcup Scott M Director filed 2018 - 2019
Royston Aaron Director filed 2018 - 2019
Ebel Ted Director filed 2018 - 2019
Cha Albert Director filed 2018 - 2018

Officers (from insider filings)

NameTitle as filedFilings
Stuart Iain Chief Scientific Officer filed 2020 - 2026
Harsch Mutya Chief Legal Officer and GC filed 2020 - 2026
Zeronda Tyler Interim CFO filed 2021 - 2026
Wiley Matthew T. Chief Commercial Officer filed 2020 - 2021
Saik Andrew Chief Financial Officer filed 2020 - 2021
Hadar Ilan CFO and Country Manager filed 2020 - 2020
Ball Kristine M See Remarks filed 2018 - 2019
Kwon Paul See Remarks filed 2018 - 2019
Krasnow Ronald A. See Remarks filed 2019 - 2019
Spellman Mary Chief Medical Officer filed 2018 - 2018

About this record

From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.

Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.